Vivanza Biosciences Limited specializes in Pharmaceuticals within the Healthcare sector.
Vivanza Biosciences Limited, with Security Code 530057, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
---|---|---|---|---|---|---|---|---|---|
2024-01-01 | 2024-03-31 | 44.23 | -4.14 | 43.93 | -0.10 | -0.99 | -0.29 | -0.10 | -2.66 |
2024-01-01 | 2024-03-31 | 22.99 | -3.78 | 22.69 | -0.09 | -0.94 | -0.29 | -0.10 | -2.67 |
2023-10-01 | 2023-12-31 | 33.66 | 1.82 | 33.84 | 0.01 | - | 0.18 | -0.01 | 1.82 |
2023-10-01 | 2023-12-31 | 65.62 | 2.06 | 65.79 | 0.01 | - | 0.18 | -0.01 | 2.06 |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 45% |
3 Years: | 16% |
TTM: | 1% |
Compounded Profit Growth | |
---|---|
10 Years: | 24% |
5 Years: | 22% |
3 Years: | 47% |
TTM: | -44% |
Stock Price CAGR | |
---|---|
10 Years: | 25% |
5 Years: | 27% |
3 Years: | -28% |
1 Year: | -43% |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 60% |
3 Years: | 41% |
TTM: | 56% |
Compounded Profit Growth | |
---|---|
10 Years: | 0% |
5 Years: | 27% |
3 Years: | 90% |
TTM: | -8% |
Stock Price CAGR | |
---|---|
10 Years: | 25% |
5 Years: | 27% |
3 Years: | -28% |
1 Year: | -43% |